Introduction Prevalent hypotheses to explain the etiology of multiple sclerosis (MS) suggest that an infectious agent encountered during adolescence might prime a disease process that only appears in the adult after a variable period of quiescence [l] . Efforts to identify a causative agent of MS have focused on finding a single virus causally linked to MS; however, it is clear from a variety of experimental model systems that many viruses are capable of inducing (Table 1) . Because of their obvious phylogenetic diversity, these agents are unlikely to share a single common mechanism of induction of disease. It seems more likely in our opinion that the host response to a viral infection of the central nervous system (CNS) is the common thread that ties together these seemingly disparate infections.
Consideration of the mechanism of induction of demyelinating disease must consider several mutually non-exclusive alternative mechanisms as summarized in Table 2 . Moreover, the pathogenic response to a viral infection might resemble in many aspects the effector mechanisms observed in the autoimmune model, experimental allergic encephalomyelitis (EAE). A fundamental difference in the viral and EAE models is that of the infections etiology;
infection is a necessary requirement of demyelination in the viral models, and it is precisely this cause-effect relationship that makes these viral models attractive platforms to explore the etiology and pathogenesis of demyelinating disease. Infection of adult mice with the MHV-JHM strain of the virus elicits a reproducible syndrome characterized by an early peak of virus replication in the brain, followed by an acute T-cell-dependent demyelinating encephalomyelitis involving both brain and spinal cord ( Figure 1 ). Active viral replication is controlled early in the MHV model: by lo-15 days after infection viral titers have dropped below the limit of detection, although viral RNA persists in white matter for several months. Notable is the uncoupling of early viral replication and later induction of demyelination. This pattern is in sharp contrast to the Theiler's murine encephalomyelitis virus (TMEV) model in which infection is followed by a productive persistent infection of white matter. These viral models allow investigation into the details of the virus-host interaction that lead to disease.
Nitric oxide and CNS disease
The gaseous free-radical nitric oxide (NO) is generated through the action of one of three isoforms of the enzyme nitric oxide synthase (NOS NOS.2 is detected within brains and spinal cords of mice during both acute and chronic stages of infection with both TMEV and MHV [6,7,11,12',13,14] . Astrocytes and cells of the monocyte/macrophage lineage were found to express the NOSZ gene in both viral infections [6,7,12' ]. Within TMEV-infected mice, both astrocytes and macrophage/monocytes stained positive for NO%? during acute and chronic stages of disease. In contrast, within MHV-infected mice the cellular source of NO% was Host-microbe interactions: fungi/viruses/parasites dependent upon the stage of disease. During the acute meningoencephalitis period (5-7 days post-infections), inflammatory macrophages were the predominant source of NO%? transcripts and protein, while astrocytes almost exclusively expressed NOS'2 during the chronic demyelinating stages of disease [6, 7] . These observations suggest that the stage of disease (i.e. acute versus chronic) might dictate the contributions of NO to the disease process.
Administration of aminoguanidine (AG -a selective inhibitor of NOSZ activity) to either TMEV-or MHVinfected mice resulted in a marked reduction in the severity of clinical disease, as weh as inflammation and demyelination, suggesting a role for NO% generated NO in the pathologies of these CNS infections [14] . This AG treatment did not affect viral replication or the ability of the animals to clear virus indicating that the reduction in the severity of disease was due to inhibition of NO% activity rather than an indirect effect. The mechanism(s) by which NO might contribute to these diseases is unknown.
In addition to its well demonstrated cytotoxic effects (alone or in combination with O,-), NOSZ generated NO may contribute to neurologic disease in a subtler manner. Administration of AG to MHV-infected mice was found to result in a selective decrease in the level of mRNA transcripts for monocyte chemoattractant protein-l (MCP-l), which is a C-C chemokine that is thought to function in attracting both T cells and macrophages during inflammatory conditions [15',16 ]. Therefore, it is possible that NO generated by NOSZ might contribute to CNS disease by promoting transcription of pro-inflammatory factors.
Cytokineslchemokines and CNS disease CNS infection with a wide variety of different viruses results in increased local expression of both cytokines and chemokines.
Production of these soluble mediators by activated T cells, macrophages and resident glia (e.g. astrocytes, oligodendrocytes and microglia) allows for a variety of responses including the initiation and maintenance of an inflammatory response through induction of adhesion molecule expression by endothelial cells, and increased expression of cytokine and chemokine receptors by infiltrating cells. Furthermore, production of these factors allows for cell-to-cell communication that might be important in controlling cell proliferation, antigen presentation, and production of potentially toxic products [17, 18] .
Both MHV and TMEV induce expression of cytokine and chemokine genes following infection of the mouse CNS. Cytokine genes that are expressed during acute MHV infection (between days 5-7 post-infections) of the CNS include interferons alpha, beta, and gamma (IFN-a, B, r), tumor necrosis factor-alpha (TNF-a), interleukins 1 alpha and beta, (IL-la and B), IL-Z, 20] . Although this profile indicates a T helper cell type 1 (Thl) profile is prevalent during infection, mRNA transcripts for IL-4 and IL-10 can be detected suggesting that a polarized Thl or Th2 response is occurring. Furthermore, the severity of infection does not appear to dictate the cytokine response within the CNS. In other words, similar cytokine profiles are obtained when the highly neurovirulent MHV-JHM or attenuated strains are used for experimental infection. Similarly, CNS infection by TMEV results in a predominantly Thl cytokine profile (e.g. IFN-y, TNF-a, and IL-Z) that did not appear to be strain dependent [Zl] .
In addition to cytokines, members of both the C-C and C-X-C family of chemokines [ZZ] are also expressed in the brains and spinal cords of MHV-infected mice; for example, the C-X-C chemokines genes encoding the cytokine response gene-Z/interferon inducible protein-10 (CRG-Z/ IP-lo), MIG, and macrophage inflammatory protein-2 (MIP-2) are up-regulated, and the C-C chemokines genes encoding MCP-1, MCP-3, MIP-1P and RANTES are also up-regulated [23"]. Although the role of these molecules in the pathogenesis of either the acute stage or the chronic stage of disease is unclear, it is conceivable that these molecules function to attract inflammatory leukocytes into the CNS following viral infection. These inflammatory leukocytes then contribute to host defense by eliminating virus. disease has yet to be determined.
Mechanisms

T cells and demyelination
One theory for the underlying pathological mechanism in MS patients is that activated, myelin-specific CD4+ T cells secrete cytokines and chemokines, which function to attract inflammatory cells into the CNS and/or activate inflammatory cells and resident glia to produce factors that might be toxic to oligodendrocytes.
Studies from animal models support the idea that T cells are important contributors to the demyelination [29] . 
Conclusions
It appears evident to us that continued presence of a viral genetic signal as either a replicating virus (i.e. in TMEV infection) or a persistent viral RNA and protein (i.e. in MHV infection) serves to drive the chronic inflammatory response in these models. Following TMEV infection anti-self reactivity has been observed as epitope spreading; reactivity with self antigens expressed on proteolipid protein (PLP) of myelin [36] . This anti-self reactivity might serve to amplify the intensity of white matter damage. However, a parallel anti-self reactivity has not been reproducibly described in the MHV model, and, therefore, it does not appear to be requisite for demyelination. Moreover, the MHV model presents an interesting challenge in answering the central question concerning what are the mechanisms of viral RNA persistent in the absence of viral replication. This paradigm would appear to fit the observation in MS of an early infection linked to later disease and influenced by genetically determined host response.
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